Results 11 to 20 of about 669,979 (252)
Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis
Medicina, 2023 Background and Objectives: Progressive pulmonary fibrosis (PPF) is a recently described term reserved for patients with fibrotic ILD other than idiopathic pulmonary fibrosis (IPF) with fast clinical deterioration. Here, survival and prognostic biomarkers
Mark G. J. P. Platenburg +3 more
doaj +1 more source
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis
ERJ Open Research, 2023 Background Telomere dysfunction can underly the development of idiopathic pulmonary fibrosis (IPF), and recent work suggests that patients with telomere syndromes might benefit from treatment with androgens, such as danazol.
Thijs W. Hoffman +4 more
doaj +1 more source
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Drugs, 2021 Progressive fibrosing interstitial lung diseases (ILDs) involve similar pathophysiological processes, indicating the potential for common approaches to treatment.
Yvette N. Lamb
semanticscholar +1 more source
Clustering of lung diseases in the family of interstitial lung disease patients
BMC Pulmonary Medicine, 2022 Background The presence of familial interstitial lung disease (ILD) has been found to predict development of progressive pulmonary fibrosis. However, the role of non-ILD lung diseases in ILD patients’ families has not yet been investigated.
Michelle Terwiel +2 more
doaj +1 more source
The prevalence and burden of interstitial lung diseases in the USA
ERJ Open Research, 2021 Interstitial lung diseases (ILDs) are a heterogeneous group of diseases (i.e. idiopathic interstitial pneumonias, autoimmune ILDs, environmental exposure-related ILDs, sarcoidosis) but share several common clinical and pathophysiological features [1, 2].
N. Jeganathan, Matheni Sathananthan
semanticscholar +1 more source
BMC Pulmonary Medicine, 2021 Background Silicosis is a progressive pneumoconiosis characterized by interstitial fibrosis following exposure to silica dust. The role of metabolic dysregulation in the pathogenesis of silicosis has not been investigated in detail.
Changjiang Xue +4 more
doaj +1 more source
Interstitial lung diseases in children [PDF]
Orphanet Journal of Rare Diseases, 2010 Interstitial lung disease (ILD) in infants and children comprises a large spectrum of rare respiratory disorders that are mostly chronic and associated with high morbidity and mortality. These disorders are characterized by inflammatory and fibrotic changes that affect alveolar walls.
Clément, Annick +4 more
openaire +5 more sources
Cluster features in fibrosing interstitial lung disease and associations with prognosis
BMC Pulmonary Medicine, 2023 Background Clustering is helpful in identifying subtypes in complex fibrosing interstitial lung disease (F-ILD) and associating them with prognosis at an early stage of the disease to improve treatment management.
Yuanying Wang +5 more
doaj +1 more source
Cells, 2021 Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance.
Els Beijer +5 more
doaj +1 more source
Role of the Microbiome in Interstitial Lung Diseases
Frontiers in Medicine, 2021 There are trillions of microorganisms in the human body, consisting of bacteria, viruses, fungi, and archaea; these collectively make up the microbiome. Recent studies suggest that the microbiome may serve as a biomarker for disease, a therapeutic target,
O. S. Chioma +3 more
semanticscholar +1 more source